An overview of frontline treatment options for patients with EGFR-mutated non–small cell lung cancer.
Developers Terminate Clinical Program for Ociperlimab in Lung Cancer
A futility analysis showed that ociperlimab was unlikely to reach the primary end point of overall survival as part of the phase 3 AdvanTIG-302 trial.
Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs
Georgios Evangelou, MD, MSc, speaks to the potential utility of neoadjuvant capecitabine/temozolomide in well-differentiated atypical carcinoids.
Tobacco Control Helps Avert Millions of Lung Cancer Deaths
A stronger commitment to tobacco control at the local, state, and federal levels may further improve progress in preventing smoking-related mortality.
Achieving Health Equity in Lung Cancer Surgery
Rian M. Hasson Charles, MD, MPH, FACS, discusses advances in equitable lung cancer screening and her experiences as a woman in thoracic oncology.
AI/ML-Based Software Improves Diagnostic Accuracy in Lung Cancer
The diagnostic accuracy of radiologists aided by the eyonis LCS AI software was greatly improved compared with when radiologists were unaided.
Deep Learning Models Expedite Biomarker Discovery, Detection in Lung Cancer
Investigators showcased feasibility of combining pathology findings with deep learning artificial intelligence to speed up biomarker detection and discovery for patients with lung cancer.